# A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

> **NCT07229313** · PHASE1 · RECRUITING · sponsor: **Kivu Bioscience Inc.** · enrollment: 76 (estimated)

## Conditions studied

- Advance Solid Tumors

## Interventions

- **DRUG:** KIVU-107

## Key facts

- **NCT ID:** NCT07229313
- **Lead sponsor:** Kivu Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-13
- **Primary completion:** 2028-03-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07229313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07229313, "A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07229313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*